(G62.0) Drug-induced polyneuropathy

More details coming soon

Icon
1 235 580 in individuals diagnosis drug-induced polyneuropathy confirmed
Icon
17 948 deaths with diagnosis drug-induced polyneuropathy
Icon
2% mortality rate associated with the disease drug-induced polyneuropathy

Diagnosis drug-induced polyneuropathy is diagnosed Men are 17.74% more likely than Women

727 384

Men receive the diagnosis drug-induced polyneuropathy

10 340 (1.4 %)

Died from this diagnosis.

100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
508 196

Women receive the diagnosis drug-induced polyneuropathy

7 608 (1.5 %)

Died from this diagnosis.

Risk Group for the Disease drug-induced polyneuropathy - Men aged 60-64 and Women aged 65-69

Icon
In Men diagnosis is most often set at age 0-95+
Icon
in in men, the disease manifests at any ageLess common in women the disease occurs at Age 0-5
Icon
In Women diagnosis is most often set at age 5-95+

Disease Features drug-induced polyneuropathy

Icon
Absence or low individual and public risk
Icon

Drug-induced polyneuropathy - what does this mean

Drug-induced polyneuropathy is a type of nerve damage caused by certain medications. it is typically characterized by numbness, tingling, and weakness in the hands and feet, as well as difficulty with coordination and balance. it can be caused by a variety of medications, including chemotherapy drugs, antibiotics, anticonvulsants, and certain antiviral medications.

What happens during the disease - drug-induced polyneuropathy

Drug-induced polyneuropathy is a type of peripheral neuropathy caused by the direct toxic effects of certain medications on the peripheral nerves. this type of neuropathy is typically seen in patients who have been taking certain medications, such as chemotherapy drugs, antibiotics, or anticonvulsants, for an extended period of time. the toxic effects of these medications cause damage to the myelin sheath surrounding the peripheral nerves, resulting in a range of symptoms including numbness, tingling, and weakness in the extremities.

Clinical Pattern

More details coming soon

How does a doctor diagnose

  • Detailed physical examination
  • Blood tests to check for underlying medical conditions
  • Electromyography (EMG) to assess the electrical activity in the muscles
  • Nerve conduction studies to measure the speed of electrical signals traveling through the nerves
  • Imaging tests such as MRI or CT scan to detect any underlying structural issues
  • Neurological tests to assess the functioning of the nervous system
  • Skin biopsy to check for nerve damage

Treatment and Medical Assistance

Main Goal: To reduce the symptoms of Drug-induced Polyneuropathy
  • Discontinue the use of any drugs that may be causing the polyneuropathy.
  • Prescribe medications to reduce inflammation.
  • Prescribe medications to relieve pain.
  • Prescribe medications to reduce nerve damage.
  • Prescribe vitamins and supplements to improve nerve health.
  • Prescribe physical therapy to improve strength and coordination.
  • Prescribe occupational therapy to improve daily functioning.
  • Provide lifestyle advice to reduce the risk of further nerve damage.
  • Refer to a specialist if necessary.
Icon
24 Days of Hospitalization Required
Icon
Average Time for Outpatient Care Not Established

Drug-induced polyneuropathy - Prevention

Drug-induced polyneuropathy can be prevented by avoiding the use of drugs that are known to cause it, such as certain antibiotics, chemotherapeutic agents, and anticonvulsants. if these drugs are necessary, then careful monitoring of the patient's symptoms and dosage should be done to minimize the risk of developing polyneuropathy. additionally, patients should be educated about the potential risks of taking these medications.